Cargando…
Adjuvant chemotherapy and HER-2-directed therapy for early-stage breast cancer in the elderly
There is a lack of sufficient evidence-based data defining the optimal adjuvant systemic therapies in older women. Recommendations are mainly based on retrospective studies, subgroup analyses within larger randomised trials and expert opinion. Treatment decisions should consider the functional fitne...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220141/ https://www.ncbi.nlm.nih.gov/pubmed/27875517 http://dx.doi.org/10.1038/bjc.2016.360 |